Stocks
Laboratory Corporation of America Holdings (LH) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 28.0% | 16.5% | 11.1% | 13.9% | 14.4% | 14.7% | ||
| Changes by years, y/y, % | +5pp | -12pp | -5pp | +3pp | +1pp | -9.1% | |||
Laboratory Corporation of America Holdings. EBITDA margin, %
Laboratory Corporation of America Holdings. EBITDA margin, changes, pp
Laboratory Corporation of America Holdings (LH) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 15.8% | 11.9% | 15.5% | 16.6% | 16.6% | 14.7% | |
| Changes by years, y/y, % | +3pp | -1pp | +1pp | +2pp | +2pp | |||
| Changes by quarters, q/q, % | +1pp | -4pp | +4pp | +1pp | 0pp | |||
